•
Feb 28

Aehr Q3 2025 Earnings Report

Aehr reported Q3 2025 results with strong revenue growth and a return to non-GAAP profitability despite a small GAAP net loss.

Key Takeaways

Aehr Test Systems delivered strong Q3 revenue growth driven by diversification into AI processors and GaN markets. Despite a GAAP net loss, the company posted solid non-GAAP profitability and grew its backlog significantly.

Revenue rose to $18.3M from $7.6M in Q3 2024, more than doubling year-over-year.

Non-GAAP EPS reached $0.07, showing strong profitability after adjustments.

Backlog increased to $21.8M, including post-quarter bookings.

The company expanded into AI processor and GaN testing markets, reducing dependence on SiC.

Total Revenue
$18.3M
Previous year: $7.56M
+142.1%
EPS
$0.07
Previous year: -$0.03
-333.3%
Effective backlog
$21.8M
Quarterly bookings
$24.1M
Gross Profit
$7.18M
Previous year: $3.16M
+127.6%
Cash and Equivalents
$31.4M
Previous year: $47.6M
-34.0%

Aehr

Aehr

Forward Guidance

Aehr withdrew its fiscal 2025 guidance due to tariff-related uncertainties but expressed confidence in long-term growth prospects driven by AI, GaN, and diversified semiconductor demand.

Positive Outlook

  • Strong customer demand for AI processor testing equipment
  • Significant growth in non-SiC revenue segments
  • Positive outlook for silicon carbide in EVs and infrastructure
  • Successful product launch of 18-wafer high-voltage system
  • New customer wins across multiple verticals including data storage and photonics

Challenges Ahead

  • Temporary withdrawal of fiscal 2025 guidance
  • Tariff uncertainty may affect customer behavior
  • GAAP net loss despite higher revenue
  • Cash position declined from prior quarter
  • Potential delays in customer shipments and orders